Mark Damante, MD

@MarkD_Jr

PGY-4 @NeurosurgeryOSU | Neurosurgical Oncology, Immuno-oncology, Drug Delivery

Joined October 2011

860Following

473Followers

Pinned

Mark Damante, MD Retweeted

Ohio State Neurosurgery Residency@NeurosurgeryOSU · Feb 22

Congratulations to @WeinbergJH, one of our PGY4 residents doing our clinical research track, on winning the Charles Kuntz IV Scholar Award at the 2025 @spinesection annual meeting!

4.0K

Mark Damante, MD Retweeted

Neurosurgery Publications@NeurosurgeryCNS · Jul 24

#NEUVisualAbstract Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control Study bit.ly/4m7cseH by @MarkD_Jr et al @OhioStateMed

1.0K

Mark Damante, MD Retweeted

Journal of Neuro-Oncology@JNeurooncol · Jul 1

Kreatsoulas et al. @NeurosurgeryOSU @RussellLonser developed and validated the MBLS to predict 90-day post-op survival in brain metastasis, offering a practical tool for pre-op risk stratification based on imaging and clinical factors. #JNO Read more:link.springer.com/article/10.100…

1.0K

Mark Damante, MD Retweeted

Guilherme Finger@guilherme_fngr · Jun 27

Honored and proud to have spent the last 3 y at OSU. Over 900 surgeries, impactful research, and exposure to cutting-edge techniques that are redefining neurosurgery. Grateful to my mentors, residents and co-fellows. Thank you for the help and friendship. Go Bucks!->Go Hoosiers!

2.0K

Mark Damante, MD Retweeted

Pelotonia Institute for Immuno-Oncology@OhioStatePIIO · Jun 13

#PIIO-1 (Anti-#GARP #CAR_T) is a milestone worth celebrating together. Grateful to the courageous patient and to everyone who made this possible. Here’s to changing lives. @Zihai Li Lab, #OSUCCC #CELL_THERAPY_LAB #Gratitude

1.0K

Mark Damante, MD Retweeted

Zihai Li, MD, PhD@Zihai · Jun 13

A milestone in our fight against cancer: today, the 1st patient received the anti-#GARP CAR-T therapy for #GBM. Immense gratitude to this courageous patient and to the incredible team whose dedication made it possible. @OhioStatePIIO @OSUCCC_James @NeurosurgeryOSU @OSUWexMed

5.0K

Mark Damante, MD Retweeted

Pelotonia Institute for Immuno-Oncology@OhioStatePIIO · Apr 11

🎉 We’re celebrating IND approval for the #first_in_human #PIIO-1 trial — a groundbreaking #CAR_T #CellTherapy for recurrent #glioblastoma!🧠 This novel approach targets GARP & delivers engineered #Tcells directly into the tumor. A major milestone for #GBM research and…

6.0K

Mark Damante, MD@MarkD_Jr · Apr 14

“Our novel CAR-T clinical trial has officially received IRB approval today. Grateful to the team for their hard work and dedication. Onward to the next phase! #ClinicalResearch #IRBApproval #TranslationalScience @OSUCCC_James @OhioStatePIIO

PPelotonia Institute for Immuno-Oncology@OhioStatePIIO · Apr 11

3.0K

Mark Damante, MD Retweeted

IU Neurosurgery@Neurosurgery_IU · Apr 10

Meet 1 of our incoming residents, Dr. Guilherme Finger! From pro basketball to nearly 60 neurosurgery publications, his journey spans from Brazil 🇧🇷, where he completed neurosurgery residency, to Ohio State—and now Indy! Welcome to the team, Dr. Finger! #Neurosurgery #Match2024

192

20.0K

Mark Damante, MD Retweeted

Ohio State Neurosurgery Residency@NeurosurgeryOSU · Apr 10

Thanks to @albertisaacsMD from @nationwidekids for the great grand rounds talk on his work on the role of immune checkpoints on neonatal intraventricular hemorrhage.

1.0K

Mark Damante, MD Retweeted

Ohio State Neurosurgery Residency@NeurosurgeryOSU · Apr 5

Honored to have Mr Nick Thomas from King’s Hospital in London join us as visiting professor for our 2025 John McGregor MD lectureship! Mr Thomas was a former fellow at OSU and gave an outstanding talk on complex craniocervical junction pathology!

2.0K

Mark Damante, MD Retweeted

Ohio State Neurosurgery Residency@NeurosurgeryOSU · Apr 5

Great presentations so far for our 2025 Resident Research Day and McGregor Lectureship! Fun to see the projects our residents are leading!

3.0K

Mark Damante, MD Retweeted

IU Neurosurgery@Neurosurgery_IU · Mar 21

Congratulations to our new Hoosiers! Guilherme Finger from Universidade de Caxias do Sul (UCS) Faculdade de Medicina, Brazil, and Raj Lavadi from Vydehi Institute, Bangalore, India.

232

19.0K

Mark Damante, MD Retweeted

Ohio State Neurosurgery Residency@NeurosurgeryOSU · Mar 21

Couldn’t be more excited to announce our 2025 match results! Welcome to Ohio State Neurosurgery Chandler Berke, Jakob Jarmula, Spencer Raub, and Bradley Wilhelmy!

243

26.0K

Mark Damante, MD Retweeted

Columbus Blue Jackets@BlueJacketsNHL · Feb 26

We're proud to partner with the Ohio Sled Hockey program to provide individuals with physical disabilities the opportunity to play our amazing game! Learn more about them at ohiosledhockey.org 🏒 @voryslaw | #HockeyIsForEveryone

8.0K

Mark Damante, MD@MarkD_Jr · Feb 22

Check out this recent study from one of our awesome residents @MarkD_Jr on one of his elective years. Our residents get two flexible elective years to pursue their passions

MMark Damante, MD@MarkD_Jr · Feb 21

We are often faced with the question of how best to manage residual tumor after a bx or subtotal resection of a GBM deemed inoperable. Past studies have shown completion resection of these lesions is safe, but does it provide oncologic benefit? journals.lww.com/neurosurgery/f…

2.0K

Mark Damante, MD@MarkD_Jr · Feb 21

MarkD_Jr's tweet image. We are often faced with the question of how best to manage residual tumor after a bx or subtotal resection of a GBM deemed inoperable. Past studies have shown completion resection of these lesions is safe, but does it provide oncologic benefit?
journals.lww.com/neurosurgery/f…

4.0K

Mark Damante, MD Retweeted

NeuroNews@NN_publishing · Jan 20

Following the first enrolments in Basking Biosciences’ RAISE trial of a novel, reversible thrombolytic, the company’s co-founder and CMO @ShahidNimjee tells @NN_publishing what this milestone could mean for the future of #Stroke care @AshuPJadhav @mihill68 neuronewsinternational.com/reversible-thr…

857